Publicacions (53) Publicacions de Javier Donate Correa

2024

  1. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

2023

  1. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  4. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

  5. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

    Antioxidants, Vol. 12, Núm. 2

  6. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  7. Targeting inflammation to treat diabetic kidney disease: the road to 2030

    Kidney International, Vol. 103, Núm. 2, pp. 282-296

  8. The Value of Klotho in Kidney Transplantation

    Transplantation, Vol. 107, Núm. 3, pp. 616-627

2022

  1. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  3. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213

  4. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients

    Renal Failure, Vol. 43, Núm. 1, pp. 821-829

  2. Iohexol plasma clearance simplified by Dried Blood Spot (DBS) sampling to measure renal function in conscious mice

    Scientific Reports, Vol. 11, Núm. 1

  3. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

    Scientific Reports, Vol. 11, Núm. 1

  4. Obesity and metabolic syndrome induce hyperfiltration, glomerulomegaly, and albuminuria in obese ovariectomized female mice and obese male mice

    Menopause (New York, N.Y.), Vol. 28, Núm. 11, pp. 1296-1306

  5. Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes

    Journal of Clinical Medicine, Vol. 10, Núm. 12, pp. 2583

  6. Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update

    Nephron, Vol. 145, Núm. 4, pp. 317-329

  7. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia

    Rheumatology (Oxford, England), Vol. 60, Núm. 1, pp. 371-379